Abstract:Background: Recent retrospective studies suggest a role for distinct microbiota in the perioperative morbidity and mortality of pancreatic head resections. Objective: We aimed to prospectively investigate the microbial colonization of critical operative sites of pancreatic head resections to identify microbial stratification factors for surgical and long-term oncologic outcomes. Methods: Prospective biomarker study applying 16S rRNA sequencing and microbial culturing to samples collected from various sites of the GI tract and surgical sites of patients during pancreatic head resections at a German single high-volume pancreatic center. Results: A total of 101 patients were included (38 non-cancer, 63 cancer patients [50 PDAC patients]) in the study. In a first data analysis series, 16S rRNA sequencing data were utilized from 96 patients to assess associations of microbiome profiles with clinical parameters and outcomes. In general, microbiome composition varied according to sampling site, cancer, age or preoperative ERCP intervention, notably for the bile microbiome. In the PDAC subcohort, compositional variance of the bile or periampullary microbiome was significantly associated with postoperative complications such as ICU admission; on a taxonomic level we observed Enterococcus spp. to be significantly more abundant in patients developing deep or organ-space surgical site infections (SSI). Elevated Enterococcus relative abundances in the upper GI tract, in turn, were associated with 6-months mortality rates. In a second step, we focused on microbiological cultures collected from bile aspirates during surgery and investigated associations with perioperative complications and long-term survival. Notably, Enterococcus spp. were among the most prevalent pathobiont isolates observed in cancer patient bile specimens that were associated with severe SSIs, and thereby elevated mortality rates up to 24 months. Clinically relevant postoperative pancreatic fistulas or severe SSI were found as other major variables determining short-term mortality in this cancer patient cohort. In the context of adverse microbiological factors, a preoperative ERCP was also observed to segregate long-term survival, and it appeared to interact with the presence of Enterococcus spp. as highest mortality rates were observed in PDAC patients with both preoperative ERCP and presence of E. faecalis in bile aspirates. Conclusions: The presence of Enterococcus spp. in bile ducts of PDAC patients undergoing pancreatic surgery represents a significant risk factor for perioperative infections and, thereby, elevated postoperative and long-term mortality. This finding supports previous data on the use of the antibiotic drug piperacillin-tazobactam as appropriate perioperative antibiotic prophylaxis for preventing adverse outcomes after pancreatoduodenectomy.

Gut Microbiota Patterns Associated with Somatostatin in Patients Undergoing Pancreaticoduodenectomy: a Prospective Study

Randomized, Placebo-Controlled Study of the Efficacy of Preoperative Somatostatin Administration in the Prevention of Postoperative Complications Following Pancreaticoduodenectomy.

Somatostatin Prevents Clinically Relevant Pancreatic Fistula in Intermediate Risk Patients after Pancreaticoduodenectomy (SPEED): A Multi-center, Randomized, Controlled Study

Somatostatin-analog Effect on Pancreatic Fistula after Radical Gastrectomy: a Pilot Randomized Controlled Trial

A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy

Systematic review and meta-analysis of somatostatin analogues in the prevention of postoperative complication after pancreaticoduodenectomy

Somatostatin vs. Octreotide for Prevention of Postoperative Pancreatic Fistula The PREFIPS Randomized Clinical Trial A FRENCH 007 – ACHBT Study

APPLICATION OF SOMATOSTATIN FOR THE PREVENTION OF COMPLICATIONS FOLLOWING PANCREATODUODENECTOMY

Risk Factors for Postoperative Pancreatic Fistula after Laparoscopic Distal Pancreatectomy Using Stapler Closure Technique from One Single Surgeon

Influence of Different Regimens of Volumetric Therapy on Perioperative Intestinal Flora in the Surgical Patients with Pancreas Tumor, a Randomized Controlled Trial Study

Prospective study on the effect of prophylactic octreotide administration in preventing pancreatic fistula after pancreatoduodenectomy

Somatostatin Versus Octreotide for Prevention of Postoperative Pancreatic Fistula: The PREFIPS Randomized Clinical Trial: A FRENCH 007-ACHBT Study

Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer

Pancreatic Fistula after Pancreaticoduodenectomy: Risk Factors and Preventive Strategies

Influence on Rehabilitation of Early Enteral Nutrition combined with Somatostatin in Patients After Pancreatodoudenectomy

A Matched-pair Analysis of Total Pancreatectomy Versus Pancreaticoduodenectomy in Patients with Pancreatic Ductal Adenocarcinoma: A Single Centre Experiment in China

Clinical Significance of Drain Fluid Culture after Pancreaticoduodenectomy

Effects of Intraoperative Fluid Balance During Pancreatoduodenectomy on Postoperative Pancreatic Fistula: an Observational Cohort Study.

Analysis of Pancreatic Fistula Risk in Patients with Laparoscopic Pancreatoduodenectomy: What Matters

Effect of Somatostatin in Advanced Gastric Cancer after D2 Radical Gastrectomy

Risk Factors and Microbial Spectrum for Infectious Complications after Pancreaticoduodenectomy.